DOI:
10.1055/s-00000027
intensiv
LinksClose Window
References
Clark WM, Wissman S, Albers GW. et al.
Recombinant tissue-type plasminogen activator (Alteplase) for
ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a
randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional
Therapy in Ischemic Stroke
JAMA 1999; 282: 2019-2026
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.